These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32468598)

  • 1. Sex-linked roles of the CRF
    Piccin A; Contarino A
    J Neurosci Res; 2020 Aug; 98(8):1561-1574. PubMed ID: 32468598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaine.
    Morisot N; Monier R; Le Moine C; Millan MJ; Contarino A
    Br J Pharmacol; 2018 May; 175(9):1504-1518. PubMed ID: 29406581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRF
    Piccin A; Contarino A
    J Neurosci Res; 2022 Jan; 100(1):309-321. PubMed ID: 32725663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
    J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues.
    Risbrough VB; Geyer MA; Hauger RL; Coste S; Stenzel-Poore M; Wurst W; Holsboer F
    Neuropsychopharmacology; 2009 May; 34(6):1494-503. PubMed ID: 19020499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of corticotropin-releasing factor CRF
    Ferrer-Pérez C; Reguilón MD; Manzanedo C; Aguilar MA; Miñarro J; Rodríguez-Arias M
    Eur J Pharmacol; 2018 Mar; 823():87-95. PubMed ID: 29391155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dorsal periaqueductal gray CRF1- and CRF2-receptor stimulation in animal models of panic.
    Sergio Tde O; Spiacci A; Zangrossi H
    Psychoneuroendocrinology; 2014 Nov; 49():321-30. PubMed ID: 25146701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRF1 and the CRF2 receptor mediate recognition memory deficits and vulnerability induced by opiate withdrawal.
    Morisot N; Contarino A
    Neuropharmacology; 2016 Jun; 105():500-507. PubMed ID: 26907806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of CRF and urocortins on the preference for social novelty of mice.
    Bagosi Z; Czébely-Lénárt A; Karasz G; Csabafi K; Jászberényi M; Telegdy G
    Behav Brain Res; 2017 May; 324():146-154. PubMed ID: 28189757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of CRF and urocortins on the sociability of mice.
    Bagosi Z; Karasz G; Czébely-Lénárt A; Csabafi K; Jászberényi M; Telegdy G
    Brain Res; 2017 May; 1663():114-122. PubMed ID: 28315311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
    Henry B; Vale W; Markou A
    J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T; Okumura T
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
    Fu Y; Neugebauer V
    J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar effect of CRF
    Spinieli RL; Leite-Panissi CRA
    Brain Res Bull; 2018 Mar; 137():187-196. PubMed ID: 29246866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.